Fund Holdings — Ally Bridge Group (NY) LLC

Total Portfolio Value
$63.00M
Total Bought
$38.38M
Total Sold
$95.25M
Net Transaction
-$56.87M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q3 2025
▲▼
Q4 2025
▲▼
Change
▲▼
Q3 2025
▲▼
Q4 2025
▲▼
Weight (%)
▲▼
Change
▲▼
ABIVAX SA(ABVX)070,000+70,00009,44014.98%+9,440
INVENTIVA SA(IVA)01,500,000+1,500,00006,97511.07%+6,975
MINERVA NEUROSCIENCES INC(NERV)01,655,500+1,655,50006,65510.56%+6,655
PRAXIS PRECISION MEDICINES I(PRAX)019,882+19,88205,8609.30%+5,860
EDGEWISE THERAPEUTICS INC(EWTX)0195,000+195,00004,8397.68%+4,839
OVID THERAPEUTICS INC(OVID)01,785,000+1,785,00002,9104.62%+2,910
PROMIS NEUROSCIENCES INC(PMN)0249,339+249,33901,7022.70%+1,702
WHITEHAWK THERAPEUTICS INC(WHWK)817,939817,93901,5541,9793.14%+425
SOLID BIOSCIENCES INC549,182413,625-135,5573,3882,3333.70%-1,056
TECTONIC THERAPEUTIC INC(TECX)138,5950-138,5952,1750—-2,175
AVALO THERAPEUTICS INC(AVTX)178,1000-178,1002,2640—-2,264
EUPRAXIA PHARMACEUTICALS INC(EPRX)915,000397,895-517,1055,3993,0044.77%-2,394
PROMIS NEUROSCIENCES INC6,233,4970-6,233,4972,6490—-2,649
TAYSHA GENE THERAPIES INC(TSHA)1,898,112457,132-1,440,9806,2072,5143.99%-3,693
TARSUS PHARMACEUTICALS INC(TARS)70,7780-70,7784,2060—-4,206
MIND MEDICINE MINDMED INC361,4440-361,4444,2610—-4,261
ARCUTIS BIOTHERAPEUTICS INC(ARQT)233,2200-233,2204,3960—-4,396
ATAI BECKLEY NV2,287,0051,713,105-573,90012,0987,00711.12%-5,092
MONOPAR THERAPEUTICS INC(MNPR)64,4550-64,4555,2640—-5,264
COMPASS PATHWAYS PLC(CMPS)1,026,3820-1,026,3825,8810—-5,881
AMYLYX PHARMACEUTICALS INC(AMLX)437,3910-437,3915,9440—-5,944
LENZ THERAPEUTICS INC(LENZ)175,3630-175,3638,1680—-8,168
ASCENDIS PHARMA A/S - ADR(ASND)51,0800-51,08010,1550—-10,155
SOLENO THERAPEUTICS INC302,483168,029-134,45420,4487,78012.35%-12,668
MADRIGAL PHARMACEUTICALS INC(MDGL)32,6620-32,66214,9810—-14,981
Page 1 of 1